Verax Biomedical, Incorporated
4 Biotech
377 Plantation Street
Worcester
Massachusetts
01605
United States
Tel: 508-755-7029
Fax: 508-755-8362
Website: http://www.veraxbiomedical.com/
24 articles about Verax Biomedical, Incorporated
-
Verax Biomedical Signs Exclusive Agreement with Fisher Healthcare for Distribution of Platelet PGD® Test in U.S.
8/19/2019
Verax Biomedical today announced that it has signed an exclusive agreement with Fisher Healthcare, a large healthcare laboratory product distributor, authorizing the company to distribute its Platelet PGD® Test through its channel in the U.S.
-
Blood Centers of America and Verax Biomedical enter into Group Purchasing Agreement for the use of the Verax Platelet PGD® Test
4/29/2019
Blood Centers of America includes over 50 members providing nearly 40% of the U.S. blood supply
-
Verax Biomedical and Healthtrust® Purchasing Group Enter Agreement for the Use of the Verax Platelet Pgd® Test
3/4/2019
HealthTrust (HPG), the industry’s only truly committed and aligned group purchasing model, serves over 1,500 hospitals including five of the seven largest IDNs in the U.S.
-
FDA Gets Verax Biomedical Clearance for Verax PGD Test
4/11/2017
-
FDA Grants New Clearance For Verax Biomedical PGD Test For Individual WBD Platelet Units
4/10/2017
-
CMS Modifies Permanent P-Code Allowing Outpatient Hospital Billing Of The Verax Biomedical PGD Test
11/15/2016
-
Centers for Medicare & Medicaid Services Issues Preliminary Decision To Allow Hospital Outpatient Billing Of The Verax Biomedical PGD Test
5/9/2016
-
Verax Biomedical Renews Commercialization Agreement With Fresenius Kabi USA For Platelet PGD Test For Bacteria
4/11/2016
-
Verax Biomedical Announces Appointment Of Paul D. Mintz, M.D. As Senior Vice President And Chief Medical Officer
2/22/2016
-
Fresenius Kabi AG and Verax Biomedical Release: FDA Clearances Allow Implementation Of 7-Day Platelets In The U.S. With The Platelet PGD Test
10/21/2015
-
Verax Biomedical, Incorporated Renews Commercialization Agreement With Fresenius Kabi USA For Platelet PGD Test For Bacteria
7/22/2015
-
Verax Biomedical, Incorporated Gains FDA Clearance For Expanded Platelet Safety Measure Testing Indications
5/26/2015
-
Verax Biomedical, Incorporated Files 510 (k) For 2 Additional Platelet Types, Also Modifies Current Product Labeling
12/1/2014
-
Verax Biomedical, Incorporated Closes $12 Million Funding Round
10/9/2013
-
Verax Biomedical, Incorporated Platelet PGD® Test Cited as Important Safety Measure to Identify Contaminated Platelets Before They Reach Patients
8/1/2012
-
Verax Biomedical, Incorporated Platelet PGD(R) Test for Bacterial Detection Now CE Marked
9/29/2008
-
Verax Biomedical, Incorporated Receives ISO Certification ISO 13485 Certification Will Enhance Product Sales in Europe and Canada
10/18/2007
-
Verax Biomedical, Incorporated Receives 510 (k) Clearance from FDA for Platelet PGD Test
9/19/2007
-
Verax Biomedical, Incorporated Appoints Scott McKenzie and Nancy Hornbaker
5/9/2007
-
Verax Biomedical, Incorporated Submits 510(k) Application to FDA for Platelet PGD Test
3/14/2007